Nada Hammad

62PUBLICATIONS
361CO-AUTHORS
Nanotoxicology, health and safetyPredictive and prognostic markersTransplantation immunologyImmunogenetics (incl. genetic immunology)Geospatial information systems and geospatial data modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (62)

|Sep 10, 2026
ANZTCT cytomegalovirus practice survey for allogeneic haemopoietic stem cell transplant and cellular therapy recipients in Australia and New Zealand.

|Aug 27, 2026
LTB-TREAT: A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma.

|Aug 21, 2026
A randomized pilot trial comparing anti-thymocyte globulin with anti-thymocyte globulin plus post transplant cyclophosphamide for prophylaxis against acute and chronic graft versus host disease in matched donor hematopoietic cell transplants - a study from the Cell Therapy Transplant Canada/ Australasian Leukemia Lymphoma Group Consortium.

|Apr 14, 2026
Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses.

Jamie E Flerlage, Dennis A Eichenauer, Michael Fuchs

|Feb 14, 2026
Total Body Irradiation in Australia and New Zealand: A 2024 Practice Survey on Changing Patterns of Care.

Sarah Li, Nada Hamad, Trieumy Tran Le

|Jun 25, 2025
Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study.

Robert Zeiser, Domenico Russo, Ron Ram

Pageof 11

Frequent Collaborators

14 joint publications

Chan Yoon Cheah

12 joint publications

Matthew Ku

11 joint publications

Pietro R Di Ciaccio

9 joint publications

Michael J Dickinson